Assessment of Abuse Potential of Cebranopadol in Humans (clinicaltrials.gov) - Jul 27, 2022 - P1 | N=38 | Completed | Sponsor: Tris Pharma, Inc. | Recruiting ➔ Completed | Trial completion date: Oct 2022 ➔ Jul 2022
Trial completion • Trial completion date • Addiction (Opioid and Alcohol)
|